Search results

Title: Searching for Novel Drug Targets (semester?), IPRO 318: Searching for Novel Drug Targets IPRO 318 Poster F07
Creator: Amin, Kathan, Himchak, Evan, Hu, Xiao-xuan, Huang, Suyao, Laster, Kyle, Lee, Hyun, Liu, Alfred, Nedrud, Joshua, Pansara, Megha, Topagi, Snehalata, Wicker, Amanda, Zwibelman, Hannah
Date: 2007-12, 2007-12
Description: Over the course of the term, IPRO 318 made progress in the “[Search] for Novel Drug Targets.” This IPRO is part of an ongoing effort to try to...
Show moreOver the course of the term, IPRO 318 made progress in the “[Search] for Novel Drug Targets.” This IPRO is part of an ongoing effort to try to find potential drug targets on pathogenic proteins. During past terms, IPRO 318 has compiled information on proteins that are known to be involved in diseases in a disease gene database. By comparing this to a database of hypothetical genes, possible high value proteins were found. This term IPRO 318 continued the lab work on the high value proteins found in previous semesters, found new ones and began lab work on those proteins, continued work on the databases, and started a new allergen database.
Deliverables for IPRO 318: Searching for Novel Drug Targets for the Fall 2007 semester
Show less

Title: Searching for Novel Drug Targets (semester?), IPRO 318
Creator: Amin, Kathan, Himchak, Evan, Hu, Xiao-xuan, Huang, Suyao, Laster, Kyle, Lee, Hyun, Liu, Alfred, Nedrud, Joshua, Pansara, Megha, Topagi, Snehalata, Wicker, Amanda, Zwibelman, Hannah
Date: 2007-12, 2007-12
Description: Over the course of the term, IPRO 318 made progress in the “[Search] for Novel Drug Targets.” This IPRO is part of an ongoing effort to try to...
Show moreOver the course of the term, IPRO 318 made progress in the “[Search] for Novel Drug Targets.” This IPRO is part of an ongoing effort to try to find potential drug targets on pathogenic proteins. During past terms, IPRO 318 has compiled information on proteins that are known to be involved in diseases in a disease gene database. By comparing this to a database of hypothetical genes, possible high value proteins were found. This term IPRO 318 continued the lab work on the high value proteins found in previous semesters, found new ones and began lab work on those proteins, continued work on the databases, and started a new allergen database.
Deliverables for IPRO 318: Searching for Novel Drug Targets for the Fall 2007 semester
Show less

Title: Searching for Novel Drug Targets (semester?), IPRO 318: Searching for Novel Drug Targets IPRO 318 Final Report F07
Creator: Amin, Kathan, Himchak, Evan, Hu, Xiao-xuan, Huang, Suyao, Laster, Kyle, Lee, Hyun, Liu, Alfred, Nedrud, Joshua, Pansara, Megha, Topagi, Snehalata, Wicker, Amanda, Zwibelman, Hannah
Date: 2007-12, 2007-12
Description: Over the course of the term, IPRO 318 made progress in the “[Search] for Novel Drug Targets.” This IPRO is part of an ongoing effort to try to...
Show moreOver the course of the term, IPRO 318 made progress in the “[Search] for Novel Drug Targets.” This IPRO is part of an ongoing effort to try to find potential drug targets on pathogenic proteins. During past terms, IPRO 318 has compiled information on proteins that are known to be involved in diseases in a disease gene database. By comparing this to a database of hypothetical genes, possible high value proteins were found. This term IPRO 318 continued the lab work on the high value proteins found in previous semesters, found new ones and began lab work on those proteins, continued work on the databases, and started a new allergen database.
Deliverables for IPRO 318: Searching for Novel Drug Targets for the Fall 2007 semester
Show less

Title: Creating an Artificial Pancreas (Semester Unknown) IPRO 308
Creator: Mathews, Rohan, Estrada, Zak, Hanley, Richard, Khalil, Shezami, Laster, Kyle, Mesquitta, Walatta, S. Park, Joon, Saseendran, Anju, Tishler, Michael, Wakeman, William
Date: 2008, 2008-05
Description: Insulin is a hormone released by pancreatic islet cells that interacts with cells to increase their permeability to glucose. Diabetes is an...
Show moreInsulin is a hormone released by pancreatic islet cells that interacts with cells to increase their permeability to glucose. Diabetes is an illness that is becoming more prevalent around the world and is linked with either abnormal insulin production, or utilization or both in the body. Diabetes may be classified into two groups: Type 1 and Type 2 In an individual with Type 1 diabetes, the pancreatic ß cells that normally produce insulin are nonexistent as they have been destroyed due to autoimmune response. In an individual with Type 2 diabetes there is tissue-wide resistance to insulin and usually some impairment of ß cells as well. Therefore, although insulin production may be present its functionality is impaired. Type 1 diabetes is typically treated with frequent extraneous insulin injections, depending on the prevailing blood glucose levels of the individual; however, in order to determine the glucose levels individuals subject themselves to periodic finger pricks throughout the day which is often uncomfortable and stressful. Mechanical devices for insulin delivery, also known as “artificial pancreases”, are currently available in the marketplace. However, these devices are not only highly invasive and painful, but also must be sanitized frequently to prevent infections. As a result, they are inconvenient and many diabetic patients choose not to use them. The goal of IPRO 308 is to develop an automated, non-invasive artificial pancreas that will be capable of determining blood glucose levels and administering an appropriate amount of insulin into the blood stream while causing minimal discomfort to the individual.
Deliverables
Show less

Title: Creating an Artificial Pancreas (Semester Unknown) IPRO 308: Creating an Artificial Pancreas IPRO 308 MidTerm Report Sp08
Creator: Mathews, Rohan, Estrada, Zak, Hanley, Richard, Khalil, Shezami, Laster, Kyle, Mesquitta, Walatta, S. Park, Joon, Saseendran, Anju, Tishler, Michael, Wakeman, William
Date: 2008, 2008-05
Description: Insulin is a hormone released by pancreatic islet cells that interacts with cells to increase their permeability to glucose. Diabetes is an...
Show moreInsulin is a hormone released by pancreatic islet cells that interacts with cells to increase their permeability to glucose. Diabetes is an illness that is becoming more prevalent around the world and is linked with either abnormal insulin production, or utilization or both in the body. Diabetes may be classified into two groups: Type 1 and Type 2 In an individual with Type 1 diabetes, the pancreatic ß cells that normally produce insulin are nonexistent as they have been destroyed due to autoimmune response. In an individual with Type 2 diabetes there is tissue-wide resistance to insulin and usually some impairment of ß cells as well. Therefore, although insulin production may be present its functionality is impaired. Type 1 diabetes is typically treated with frequent extraneous insulin injections, depending on the prevailing blood glucose levels of the individual; however, in order to determine the glucose levels individuals subject themselves to periodic finger pricks throughout the day which is often uncomfortable and stressful. Mechanical devices for insulin delivery, also known as “artificial pancreases”, are currently available in the marketplace. However, these devices are not only highly invasive and painful, but also must be sanitized frequently to prevent infections. As a result, they are inconvenient and many diabetic patients choose not to use them. The goal of IPRO 308 is to develop an automated, non-invasive artificial pancreas that will be capable of determining blood glucose levels and administering an appropriate amount of insulin into the blood stream while causing minimal discomfort to the individual.
Deliverables
Show less

Title: Creating an Artificial Pancreas (Semester Unknown) IPRO 308: Creating an Artificial Pancreas IPRO 308 Final Presentation Sp08
Creator: Mathews, Rohan, Estrada, Zak, Hanley, Richard, Khalil, Shezami, Laster, Kyle, Mesquitta, Walatta, S. Park, Joon, Saseendran, Anju, Tishler, Michael, Wakeman, William
Date: 2008, 2008-05
Description: Insulin is a hormone released by pancreatic islet cells that interacts with cells to increase their permeability to glucose. Diabetes is an...
Show moreInsulin is a hormone released by pancreatic islet cells that interacts with cells to increase their permeability to glucose. Diabetes is an illness that is becoming more prevalent around the world and is linked with either abnormal insulin production, or utilization or both in the body. Diabetes may be classified into two groups: Type 1 and Type 2 In an individual with Type 1 diabetes, the pancreatic ß cells that normally produce insulin are nonexistent as they have been destroyed due to autoimmune response. In an individual with Type 2 diabetes there is tissue-wide resistance to insulin and usually some impairment of ß cells as well. Therefore, although insulin production may be present its functionality is impaired. Type 1 diabetes is typically treated with frequent extraneous insulin injections, depending on the prevailing blood glucose levels of the individual; however, in order to determine the glucose levels individuals subject themselves to periodic finger pricks throughout the day which is often uncomfortable and stressful. Mechanical devices for insulin delivery, also known as “artificial pancreases”, are currently available in the marketplace. However, these devices are not only highly invasive and painful, but also must be sanitized frequently to prevent infections. As a result, they are inconvenient and many diabetic patients choose not to use them. The goal of IPRO 308 is to develop an automated, non-invasive artificial pancreas that will be capable of determining blood glucose levels and administering an appropriate amount of insulin into the blood stream while causing minimal discomfort to the individual.
Deliverables
Show less

Title: Creating an Artificial Pancreas (Semester Unknown) IPRO 308: Creating an Artificial Pancreas IPRO 308 Final Report Sp08_redacted
Creator: Mathews, Rohan, Estrada, Zak, Hanley, Richard, Khalil, Shezami, Laster, Kyle, Mesquitta, Walatta, S. Park, Joon, Saseendran, Anju, Tishler, Michael, Wakeman, William
Date: 2008, 2008-05
Description: Insulin is a hormone released by pancreatic islet cells that interacts with cells to increase their permeability to glucose. Diabetes is an...
Show moreInsulin is a hormone released by pancreatic islet cells that interacts with cells to increase their permeability to glucose. Diabetes is an illness that is becoming more prevalent around the world and is linked with either abnormal insulin production, or utilization or both in the body. Diabetes may be classified into two groups: Type 1 and Type 2 In an individual with Type 1 diabetes, the pancreatic ß cells that normally produce insulin are nonexistent as they have been destroyed due to autoimmune response. In an individual with Type 2 diabetes there is tissue-wide resistance to insulin and usually some impairment of ß cells as well. Therefore, although insulin production may be present its functionality is impaired. Type 1 diabetes is typically treated with frequent extraneous insulin injections, depending on the prevailing blood glucose levels of the individual; however, in order to determine the glucose levels individuals subject themselves to periodic finger pricks throughout the day which is often uncomfortable and stressful. Mechanical devices for insulin delivery, also known as “artificial pancreases”, are currently available in the marketplace. However, these devices are not only highly invasive and painful, but also must be sanitized frequently to prevent infections. As a result, they are inconvenient and many diabetic patients choose not to use them. The goal of IPRO 308 is to develop an automated, non-invasive artificial pancreas that will be capable of determining blood glucose levels and administering an appropriate amount of insulin into the blood stream while causing minimal discomfort to the individual.
Deliverables
Show less

Title: Creating an Artificial Pancreas (Semester Unknown) IPRO 308: Creating an Artificial Pancreas IPRO 308 Poster Sp08
Creator: Mathews, Rohan, Estrada, Zak, Hanley, Richard, Khalil, Shezami, Laster, Kyle, Mesquitta, Walatta, S. Park, Joon, Saseendran, Anju, Tishler, Michael, Wakeman, William
Date: 2008, 2008-05
Description: Insulin is a hormone released by pancreatic islet cells that interacts with cells to increase their permeability to glucose. Diabetes is an...
Show moreInsulin is a hormone released by pancreatic islet cells that interacts with cells to increase their permeability to glucose. Diabetes is an illness that is becoming more prevalent around the world and is linked with either abnormal insulin production, or utilization or both in the body. Diabetes may be classified into two groups: Type 1 and Type 2 In an individual with Type 1 diabetes, the pancreatic ß cells that normally produce insulin are nonexistent as they have been destroyed due to autoimmune response. In an individual with Type 2 diabetes there is tissue-wide resistance to insulin and usually some impairment of ß cells as well. Therefore, although insulin production may be present its functionality is impaired. Type 1 diabetes is typically treated with frequent extraneous insulin injections, depending on the prevailing blood glucose levels of the individual; however, in order to determine the glucose levels individuals subject themselves to periodic finger pricks throughout the day which is often uncomfortable and stressful. Mechanical devices for insulin delivery, also known as “artificial pancreases”, are currently available in the marketplace. However, these devices are not only highly invasive and painful, but also must be sanitized frequently to prevent infections. As a result, they are inconvenient and many diabetic patients choose not to use them. The goal of IPRO 308 is to develop an automated, non-invasive artificial pancreas that will be capable of determining blood glucose levels and administering an appropriate amount of insulin into the blood stream while causing minimal discomfort to the individual.
Deliverables
Show less

Title: Creating an Artificial Pancreas (Semester Unknown) IPRO 308: Creating an Artificial Pancreas IPRO 308 Project Plan Sp08
Creator: Mathews, Rohan, Estrada, Zak, Hanley, Richard, Khalil, Shezami, Laster, Kyle, Mesquitta, Walatta, S. Park, Joon, Saseendran, Anju, Tishler, Michael, Wakeman, William
Date: 2008, 2008-05
Description: Insulin is a hormone released by pancreatic islet cells that interacts with cells to increase their permeability to glucose. Diabetes is an...
Show moreInsulin is a hormone released by pancreatic islet cells that interacts with cells to increase their permeability to glucose. Diabetes is an illness that is becoming more prevalent around the world and is linked with either abnormal insulin production, or utilization or both in the body. Diabetes may be classified into two groups: Type 1 and Type 2 In an individual with Type 1 diabetes, the pancreatic ß cells that normally produce insulin are nonexistent as they have been destroyed due to autoimmune response. In an individual with Type 2 diabetes there is tissue-wide resistance to insulin and usually some impairment of ß cells as well. Therefore, although insulin production may be present its functionality is impaired. Type 1 diabetes is typically treated with frequent extraneous insulin injections, depending on the prevailing blood glucose levels of the individual; however, in order to determine the glucose levels individuals subject themselves to periodic finger pricks throughout the day which is often uncomfortable and stressful. Mechanical devices for insulin delivery, also known as “artificial pancreases”, are currently available in the marketplace. However, these devices are not only highly invasive and painful, but also must be sanitized frequently to prevent infections. As a result, they are inconvenient and many diabetic patients choose not to use them. The goal of IPRO 308 is to develop an automated, non-invasive artificial pancreas that will be capable of determining blood glucose levels and administering an appropriate amount of insulin into the blood stream while causing minimal discomfort to the individual.
Deliverables
Show less

Title: Creating an Artificial Pancreas (Semester Unknown) IPRO 308: Creating an Artificial Pancreas IPRO 308 Brochure Sp08
Creator: Mathews, Rohan, Estrada, Zak, Hanley, Richard, Khalil, Shezami, Laster, Kyle, Mesquitta, Walatta, S. Park, Joon, Saseendran, Anju, Tishler, Michael, Wakeman, William
Date: 2008, 2008-05
Description: Insulin is a hormone released by pancreatic islet cells that interacts with cells to increase their permeability to glucose. Diabetes is an...
Show moreInsulin is a hormone released by pancreatic islet cells that interacts with cells to increase their permeability to glucose. Diabetes is an illness that is becoming more prevalent around the world and is linked with either abnormal insulin production, or utilization or both in the body. Diabetes may be classified into two groups: Type 1 and Type 2 In an individual with Type 1 diabetes, the pancreatic ß cells that normally produce insulin are nonexistent as they have been destroyed due to autoimmune response. In an individual with Type 2 diabetes there is tissue-wide resistance to insulin and usually some impairment of ß cells as well. Therefore, although insulin production may be present its functionality is impaired. Type 1 diabetes is typically treated with frequent extraneous insulin injections, depending on the prevailing blood glucose levels of the individual; however, in order to determine the glucose levels individuals subject themselves to periodic finger pricks throughout the day which is often uncomfortable and stressful. Mechanical devices for insulin delivery, also known as “artificial pancreases”, are currently available in the marketplace. However, these devices are not only highly invasive and painful, but also must be sanitized frequently to prevent infections. As a result, they are inconvenient and many diabetic patients choose not to use them. The goal of IPRO 308 is to develop an automated, non-invasive artificial pancreas that will be capable of determining blood glucose levels and administering an appropriate amount of insulin into the blood stream while causing minimal discomfort to the individual.
Deliverables
Show less

Title: Creating an Artificial Pancreas (Semester Unknown) IPRO 308: Creating an Artificial Pancreas IPRO 308 Ethics Sp08
Creator: Mathews, Rohan, Estrada, Zak, Hanley, Richard, Khalil, Shezami, Laster, Kyle, Mesquitta, Walatta, S. Park, Joon, Saseendran, Anju, Tishler, Michael, Wakeman, William
Date: 2008, 2008-05
Description: Insulin is a hormone released by pancreatic islet cells that interacts with cells to increase their permeability to glucose. Diabetes is an...
Show moreInsulin is a hormone released by pancreatic islet cells that interacts with cells to increase their permeability to glucose. Diabetes is an illness that is becoming more prevalent around the world and is linked with either abnormal insulin production, or utilization or both in the body. Diabetes may be classified into two groups: Type 1 and Type 2 In an individual with Type 1 diabetes, the pancreatic ß cells that normally produce insulin are nonexistent as they have been destroyed due to autoimmune response. In an individual with Type 2 diabetes there is tissue-wide resistance to insulin and usually some impairment of ß cells as well. Therefore, although insulin production may be present its functionality is impaired. Type 1 diabetes is typically treated with frequent extraneous insulin injections, depending on the prevailing blood glucose levels of the individual; however, in order to determine the glucose levels individuals subject themselves to periodic finger pricks throughout the day which is often uncomfortable and stressful. Mechanical devices for insulin delivery, also known as “artificial pancreases”, are currently available in the marketplace. However, these devices are not only highly invasive and painful, but also must be sanitized frequently to prevent infections. As a result, they are inconvenient and many diabetic patients choose not to use them. The goal of IPRO 308 is to develop an automated, non-invasive artificial pancreas that will be capable of determining blood glucose levels and administering an appropriate amount of insulin into the blood stream while causing minimal discomfort to the individual.
Deliverables
Show less

repository.iit

Search the repository

Query

Refine Results

Type

Date

Department

Subject

Creator

Rights